gip/glp-1 receptor agonist New strategies for the treatment of obesity and metabolic dysfunctions GLP-1 & GIP Agonists |
Description
Addressing Mental Health Concerns Integrating psychological support into obesity treatment plans can help manage emotional well-being
Boehringer Ingelheim maintains niche loyalty for dulaglutide via its auto-injector design, though share erosion is visible
Patients with cardiovascular (CV) risk, for instance, FDCs planned with sitagliptin and metformin or empagliflozin have shown superiority versus monotherapy on the grounds of treatment efficacy in clinical trials [29]
Thus, translation of GIP physiology and pharmacology across species can be challenging (122)
